Experience of Lung Transplantation in Patients with Lymphangioleiomyomatosis at a Brazilian Reference Centre

ConclusionsThis data reinforces the role of LT for LAM patients with end-stage disease. The use of sirolimus seems to be safe before LT and the occurrence of complications after LT, including those LAM-related, should be continuously monitored.
Source: Lung - Category: Respiratory Medicine Source Type: research